Vanguard Group Inc Ptc Therapeutics, Inc. Transaction History

Vanguard Group Inc

$5.37 Trillion
Q1 2025

A detailed history of Vanguard Group Inc transactions in Ptc Therapeutics, Inc. stock. As of the latest transaction made, Vanguard Group Inc holds 8,607,372 shares of PTCT stock, worth $420 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares

8,607,372

Previous 9,178,822 6.23%

Holding current value

$420 Million

Previous $414 Million 5.86%

% of portfolio

0.01%

Previous 0.01%

16 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2025 May 09, 2025	SELL	$41.81 - $57.17 $23.9 Million - $32.7 Million	-571,450 Reduced 6.23%	8,607,372 $439 Million
Q4 2024 Feb 11, 2025	BUY	$34.99 - $52.07 $1.88 Million - $2.8 Million	53,688 Added 0.59%	9,178,822 $414 Million
Q3 2024 Nov 13, 2024	BUY	$30.39 - $37.66 $4.6 Million - $5.7 Million	151,363 Added 1.69%	9,125,134 $339 Million
Q2 2024 Aug 13, 2024	SELL	$24.69 - $40.12 $9.76 Million - $15.9 Million	-395,243 Reduced 4.22%	8,973,771 $274 Million
Q1 2024 May 10, 2024	BUY	$24.15 - $31.95 $13.7 Million - $18.2 Million	568,171 Added 6.46%	9,369,014 $273 Million
Q4 2023 Feb 14, 2024	BUY	$18.07 - $29.37 $15.5 Million - $25.1 Million	855,354 Added 10.77%	8,800,843 $243 Million
Q3 2023 Nov 14, 2023	BUY	$22.41 - $41.99 $8.81 Million - $16.5 Million	393,012 Added 5.2%	7,945,489 $178 Million
Q2 2023 Aug 14, 2023	SELL	$40.4 - $59.1 $1.43 Million - $2.09 Million	-35,305 Reduced 0.47%	7,552,477 $307 Million
Q1 2023 May 15, 2023	BUY	$38.16 - $48.86 $9.47 Million - $12.1 Million	248,262 Added 3.38%	7,587,782 $368 Million
Q4 2022 Feb 10, 2023	BUY	$33.53 - $54.79 $4.29 Million - $7 Million	127,800 Added 1.77%	7,339,520 $280 Million
Q3 2022 Nov 14, 2022	BUY	$41.85 - $53.85 $1.17 Million - $1.51 Million	28,028 Added 0.39%	7,211,720 $362 Million
Q2 2022 Aug 12, 2022	BUY	$25.6 - $45.23 $6.42 Million - $11.3 Million	250,616 Added 3.61%	7,183,692 $288 Million
Q1 2022 May 13, 2022	BUY	$33.33 - $44.6 $1.47 Million - $1.97 Million	44,167 Added 0.64%	6,933,076 $259 Million
Q4 2021 Feb 14, 2022	BUY	$35.36 - $41.86 $4.63 Million - $5.48 Million	130,935 Added 1.94%	6,888,909 $274 Million
Q3 2021 Nov 12, 2021	BUY	$37.01 - $44.74 $863,961 - $1.04 Million	23,344 Added 0.35%	6,757,974 $251 Million
Q2 2021 Aug 13, 2021	BUY	$37.95 - $49.37 $256 Million - $332 Million	6,734,630 New	6,734,630 $285 Million

Others Institutions Holding PTCT

# of Institutions

284

Shares Held

78.5M

Call Options Held

223K

Put Options Held

156K

View Full List

About PTC THERAPEUTICS, INC.

Ticker PTCT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 71,541,000
Market Cap $3.49B
Description
PTC Therapeutics, Inc., a biopharmaceutical company, focuses on the discovery, development, and commercialization of medicines to patients with rare disorders. Its portfolio pipeline includes commercial products and product candidates in various stages of development, including clinical, pre-clinical and research and discovery stages, focuses on...

More about PTCT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Vanguard Group Inc, based on Form 13F filings with the SEC.

News

Stay updated on Vanguard Group Inc with notifications on news.

Account

Vanguard Group Inc Ptc Therapeutics, Inc. Transaction History